Data as of 3:36pm ET
| -0.0362 / -5.75%|
The 1 analysts offering 12-month price forecasts for Cleveland Biolabs Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +236.81% increase from the last price of 0.59.
The current consensus among 1 polled investment analysts is to Hold stock in Cleveland Biolabs Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.